There is no single rash that signals pancreatic cancer. Instead, the disease can trigger several distinct skin changes depending on the type of tumor, where it sits in the pancreas, and whether it has spread. The most recognized is a blistering, migrating rash called necrolytic migratory erythema, linked specifically to a rare hormone-secreting pancreatic tumor. But pancreatic cancer can also cause tender leg nodules, an umbilical lump, cord-like swollen veins, and even a sudden crop of warty growths on the trunk. Each of these looks different and arises through a different mechanism, so understanding which skin sign points where matters for getting the right diagnosis quickly.
Necrolytic Migratory Erythema
The skin change most closely tied to a pancreatic tumor is necrolytic migratory erythema, often shortened to NME. It is considered a hallmark of the glucagonoma syndrome, a condition caused by a slow-growing neuroendocrine tumor in the pancreas that pumps out excess glucagon.1PubMed Central. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome In a case series of seven patients, every one of them first visited a dermatologist complaining of a painful, itchy rash that had been present for months before anyone suspected a pancreatic tumor.2Scientific Reports. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma
What does NME actually look like? It typically starts as patches of redness in skin-fold areas: the groin, buttocks, perineum, and lower abdomen. It can also appear on the extremities, face, and lower back. The red patches spread outward over days to weeks, and as they expand, the centers often break down, becoming crusty, blistered, or eroded. Some lesions weep fluid; others develop areas of necrotic tissue in their centers. The borders tend to be irregular, and patches can merge into large areas of affected skin.2Scientific Reports. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma The “migratory” part of the name is accurate: old patches heal while new ones appear nearby, giving the rash a constantly shifting pattern that can make it hard to pin down.
Under a microscope, a biopsy of NME shows distinctive changes in the upper layer of the skin. The cells of the upper epidermis swell, develop fluid-filled spaces (vacuolization), and eventually die off in a pattern called necrolysis.3Indian Journal of Dermatology, Venereology and Leprology. Glucagonoma syndrome with atypical necrolytic migratory erythema Research suggests that this destruction may be driven by a form of cellular self-digestion triggered by malnutrition at the skin level, rather than by the immune-mediated inflammation seen in many other rashes.4PubMed. Autophagy in malnutrition-associated dermatoses
NME is easily mistaken for eczema, psoriasis, or a fungal infection, and patients often bounce between dermatologists and primary care doctors for months. In one reported case, a patient’s rash was treated as common dermatitis before imaging eventually revealed adenocarcinoma in the head of the pancreas.5PubMed Central. An uncommon case of pancreatic adenocarcinoma revealed by dermatitis Because NME is the presenting symptom in many glucagonoma cases, recognizing it early can be the difference between catching the tumor while it is still resectable and finding it after it has already spread.6PubMed Central. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor
Why Glucagonomas Damage the Skin
The excess glucagon flooding the bloodstream from a glucagonoma drives amino acid levels in the blood down to abnormally low levels. The skin, which turns over rapidly and has high protein demands, appears to be one of the first tissues to suffer. In a study that tested this idea directly, supplementing a glucagonoma patient with intravenous amino acids brought most plasma amino acid levels back to normal, and the rash disappeared rapidly. Importantly, the researchers withheld zinc and fatty acids during part of the experiment to rule those out as causes, and the rash still cleared as long as amino acids were provided.7PubMed. Amino acid deficiency and the skin rash associated with glucagonoma This strongly suggests that the skin breakdown in NME is fundamentally a nutritional injury to the epidermis rather than a direct toxic effect of the tumor itself.
Pancreatic Panniculitis
A completely different skin sign shows up in some cases of pancreatic adenocarcinoma (the much more common type of pancreatic cancer) and, occasionally, in severe pancreatitis. Pancreatic panniculitis produces tender, red-brown nodules under the skin, most often on the lower legs. These bumps are firm, poorly defined, and can ulcerate, sometimes draining an oily, brownish fluid.8CMAJ. Pancreatic panniculitis They can also appear on the arms, trunk, and even the breasts.9PubMed Central. Pancreatic panniculitis associated with pancreatic carcinoma
The mechanism here is different from NME. When a pancreatic tumor (or inflamed pancreas) releases digestive enzymes like lipase and trypsin into the bloodstream in abnormally high amounts, those enzymes can attack fat deposits far from the abdomen. They digest the subcutaneous fat in the legs and elsewhere, creating pockets of fat necrosis that the body then reacts to with inflammation.10PubMed. Subcutaneous fat necrosis/panniculitis and polyarthritis associated with acinar cell carcinoma of the pancreas In some patients, this same enzyme-driven destruction also hits the fat around joints, producing painful swelling in the hands, knees, and ankles alongside the skin nodules. One case report describes a woman with prior breast cancer who developed abrupt painful leg nodules and progressive joint pain in her hands, knees, and ankles as the first sign that pancreatic cancer had developed.11PubMed Central. Pancreatitis, panniculitis, polyarthritis syndrome as an initial manifestation of metastatic pancreatic cancer in a breast cancer patient
If you are looking at pancreatic panniculitis versus the more common causes of tender leg bumps (like erythema nodosum, which is often linked to infections or inflammatory bowel disease), the oily drainage is a major distinguishing feature. Most other forms of panniculitis do not produce that characteristic greasy discharge.
Sister Mary Joseph’s Nodule
A hard lump in or near the belly button can be a sign that a cancer inside the abdomen has spread to the skin. This is called a Sister Mary Joseph’s nodule, named after the surgical assistant who first noticed the pattern in the early 1900s. It is rare, but pancreatic cancer is one of the internal malignancies known to cause it.12PubMed Central. Sister Mary Joseph’s nodule as a first sign of pancreatic cancer
The nodule is firm, irregular, and usually between half a centimeter and two centimeters across, though some can grow much larger. Its surface may be darkly pigmented or ulcerated.13PubMed Central. Case of a Sister Mary Joseph’s Nodule in Pancreatic Adenocarcinoma: a Diagnostic challenge In one reported case, an 84-year-old woman presented with bleeding from a reddish, ulcerated, multinodular mass at the belly button. Biopsy confirmed adenocarcinoma cells in the skin, and imaging revealed a tumor in the tail of the pancreas.14PubMed Central. Sister Mary Joseph’s Nodule Presenting with an Ulcerated Umbilicus as an External Diagnostic Clue Revealing a Deeply Situated Pancreatic Tail Cancer
Finding a Sister Mary Joseph’s nodule is generally a sign of advanced disease, since the cancer cells have already traveled from the original tumor to the skin. Still, when a new, unexplained umbilical lump appears in an older adult, especially one with weight loss or abdominal discomfort, it warrants imaging of the abdomen to check for an underlying malignancy.
Migratory Thrombophlebitis
Not every skin-visible sign of pancreatic cancer is a rash in the traditional sense. Trousseau syndrome, also called migratory thrombophlebitis, involves recurring episodes of inflamed, clotted veins that appear as firm, tender, cord-like swellings under the skin. These can show up on the arms, legs, chest wall, or abdominal wall, and they tend to shift location over time.15PubMed Central. Thrombophlebitis Migrans (Trousseau Syndrome) in Pancreatic Adenocarcinoma: An Autopsy Report The overlying skin turns red and warm. Pancreatic adenocarcinoma is one of the cancers most commonly associated with this clotting phenomenon, because the tumor secretes substances that activate the coagulation system.
From the outside, migratory thrombophlebitis looks like reddened streaks following the path of a superficial vein, with a palpable firm cord underneath. If you press on it, it is tender. The migratory nature is the distinguishing clue: a clot forms in one vein, resolves, and then another appears elsewhere, sometimes within weeks. Ordinary blood clots rarely behave this way, so a pattern of unexplained, wandering superficial clots should prompt investigation for an occult cancer.
Sudden Appearance of Seborrheic Keratoses
The sign of Leser-Trélat is a paraneoplastic phenomenon in which a person suddenly develops large numbers of seborrheic keratoses, the waxy, raised, stuck-on-looking growths that are common in older adults. Individually, seborrheic keratoses are harmless and extremely common. What sets the Leser-Trélat sign apart is the speed: dozens of new keratoses appearing over weeks to months, or existing ones rapidly increasing in size and number. This eruption tends to develop around the same time as the underlying cancer.16Russian Journal of Skin and Venereal Diseases. Leser–Trelat sign in cosmetologist’s practice
Gastrointestinal adenocarcinomas, including pancreatic cancer, are the most commonly associated tumor type, accounting for roughly half of reported cases.16Russian Journal of Skin and Venereal Diseases. Leser–Trelat sign in cosmetologist’s practice The growths themselves look the same as ordinary seborrheic keratoses: brown or tan, well-demarcated, with a waxy or velvety surface. They tend to cluster on the trunk. Because seborrheic keratoses are so common in the elderly, the Leser-Trélat sign is easy to dismiss. The red flag is tempo, not appearance. A person who has always had a few keratoses suddenly sprouting many more deserves at least a conversation about screening, even though the association remains uncommon.
When the Rash Comes from Treatment
People undergoing treatment for pancreatic cancer can develop a very different kind of rash that has nothing to do with the tumor’s biology. Erlotinib, a targeted therapy sometimes combined with gemcitabine chemotherapy for advanced pancreatic cancer, causes a distinctive acne-like rash in a substantial portion of patients. In one large observational study of 270 patients, about a third developed a rash, with roughly equal numbers experiencing mild and moderate-to-severe grades.17PubMed Central. Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib
The erlotinib rash typically appears within the first week or two of treatment. It looks like clusters of small, red, pus-filled bumps concentrated on the face, neck, and upper chest. Despite being commonly called “acneiform,” it is not acne and should not be treated with standard acne medications. It can also involve crusting and itching, and in some cases resembles a type of folliculitis.18Journal of the Pancreas. Erlotinib-Induced Skin Rash. Pathogenesis, Clinical Significance and Management in Pancreatic Cancer Patients
Here is where the erlotinib rash gets counterintuitive: developing this rash is actually a favorable sign. A meta-analysis found that patients who developed a rash during erlotinib-gemcitabine therapy survived roughly twice as long as those who did not, with a median overall survival of about 9 months versus 5 months. The benefit was even more pronounced with higher-grade rashes.19PubMed Central. Predictive role of skin rash in advanced pancreatic cancer patients treated with gemcitabine and erlotinib The rash appears to be a sign that the drug is effectively blocking the growth-factor receptor it targets. Oncologists sometimes use rash development as a rough indicator that the treatment is working, though this does not mean deliberately worsening the rash would improve outcomes.
How These Skin Signs Respond to Treatment
For NME associated with glucagonoma, the rash often clears remarkably fast once the tumor is addressed. In one case series, all six patients who underwent surgical removal of the glucagonoma saw their skin lesions begin improving within a day to a week after surgery, as glucagon levels dropped sharply.2Scientific Reports. Necrolytic migratory erythema is an important visual cutaneous clue of glucagonoma For patients who cannot have surgery, somatostatin analogs (drugs that suppress hormone secretion) can help control the rash. A scoping review found that about 80 percent of patients treated with these drugs showed improvement in their NME, with skin symptoms resolving in an average of roughly six weeks.20PubMed Central. Exceptional Response of Necrolytic Migratory Erythema to Octreotide in a Patient with Glucagonoma Amino acid infusions can also help in the short term, given the nutritional mechanism behind the rash.
Pancreatic panniculitis tends to improve when the underlying pancreatic disease is controlled, whether through surgery, treatment of pancreatitis, or chemotherapy. The Sister Mary Joseph’s nodule, being a direct deposit of cancer cells, generally requires treatment of the cancer itself and may shrink with chemotherapy but rarely disappears entirely without surgery. Trousseau syndrome is managed with anticoagulation, though controlling the underlying cancer is the only way to truly resolve the clotting tendency.
Telling These Skin Signs Apart
Because the various skin manifestations of pancreatic cancer look nothing like each other, recognizing which type you are looking at is essential. Here is a quick comparison of the main features:
- NME: Spreading red patches with crusty, eroded, or blistering centers. Found in skin folds, groin, buttocks. Migrates over time. Intensely itchy and painful.
- Panniculitis: Firm, tender, red-brown bumps under the skin, mainly on the shins and lower legs. May drain an oily fluid.
- SMJN: A single hard, irregular lump at the belly button. May be dark-colored or ulcerated. Usually painless until advanced.
- Trousseau syndrome: Firm, cord-like swelling along a superficial vein with red, warm overlying skin. Moves to different veins over weeks.
- Leser-Trélat: Rapid appearance of many waxy, raised, brown growths (seborrheic keratoses), mainly on the trunk.
- Erlotinib rash: Acne-like red bumps with pus, mainly on the face, neck, and upper chest. Appears within days of starting the drug.
None of these is common. Pancreatic cancer overall is far more likely to present with jaundice, unexplained weight loss, new-onset diabetes, or deep abdominal pain than with any skin change. But when a skin sign does appear as the first clue, it often shows up months before other symptoms become obvious. That lag time is why dermatologists sometimes end up being the first clinicians to raise suspicion of a pancreatic tumor, particularly in glucagonoma cases where NME is the presenting complaint.6PubMed Central. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor If you notice any of these patterns, and especially if they are accompanied by unexplained weight loss, fatigue, or digestive changes, bringing them to a doctor’s attention sooner rather than later is worthwhile. The earlier a pancreatic tumor is found, the more treatment options remain on the table.
Sweet’s Syndrome and Other Rare Associations
Beyond the more established skin signs, a handful of case reports have linked pancreatic tumors to Sweet’s syndrome, an inflammatory skin condition that causes sudden crops of tender, red-purple plaques, often on the arms, face, and neck. Sweet’s syndrome is more commonly associated with blood cancers, but a few documented cases have appeared alongside pancreatic neoplasms. The plaques look swollen, almost like raised welts, and tend to have sharp borders. They develop quickly and are often accompanied by fever and a high white blood cell count. It remains an exceptionally rare association, and any single case of Sweet’s syndrome is far more likely to be related to infection, autoimmune disease, or a blood cancer than to a pancreatic tumor. Still, when Sweet’s syndrome occurs in someone with gastrointestinal symptoms and no obvious alternative cause, clinicians may consider abdominal imaging.
Other one-off paraneoplastic skin reports in the pancreatic cancer literature include dermatomyositis (a muscle and skin condition that produces a violet-colored rash on the eyelids and knuckles) and pemphigus (blistering of the skin and mucous membranes). These are extremely uncommon and are not specific to pancreatic cancer. They serve mostly as reminders that the immune system can respond to internal tumors in unexpected ways that show up on the skin surface.